skip to content
Home

Statistical Laboratory

Professor David Spiegelhalter

Publications

Communicating personalized risks from COVID-19: Guidelines from an empirical study
ALJ Freeman, J Kerr, G Recchia, CR Schneider, ACE Lawrence, L Finikarides, G Luoni, S Dryhurst, D Spiegelhalter
– Royal Society Open Science
(2021)
8,
201721
(doi: 10.1098/rsos.201721)
The effects of quality of evidence communication on perception of public health information about COVID-19: two randomised controlled trials
C Schneider, A Freeman, D Spiegelhalter, S van der Linden
(2021)
2021.04.07.21255010
(doi: 10.1101/2021.04.07.21255010)
Sound human, steer clear of jargon, and be prepared.
K McConway, D Spiegelhalter
– Signif (Oxf)
(2021)
18,
32
(doi: 10.1111/1740-9713.01508)
COVID-19 risk perception: A longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom
CR Schneider, S Dryhurst, J Kerr, ALJ Freeman, G Recchia, D Spiegelhalter, S van der Linden
– Journal of Risk Research
(2021)
24,
294
(doi: 10.1080/13669877.2021.1890637)
What is my covid risk?
S Finnikin, DJ Spiegelhalter
– The BMJ
(2021)
372,
n637
(doi: 10.1136/bmj.n637)
The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis
C Jackson, ALJ Freeman, Z Szlamka, DJ Spiegelhalter
– PLoS ONE
(2021)
16,
e0246441
(doi: 10.1371/journal.pone.0246441)
Five rules for evidence communication.
M Blastland, ALJ Freeman, S van der Linden, TM Marteau, D Spiegelhalter
– Nature
(2020)
587,
362
(doi: 10.1038/d41586-020-03189-1)
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study
AK Clift, CAC Coupland, RH Keogh, K Diaz-Ordaz, E Williamson, EM Harrison, A Hayward, H Hemingway, P Horby, N Mehta, J Benger, K Khunti, D Spiegelhalter, A Sheikh, J Valabhji, RA Lyons, J Robson, MG Semple, F Kee, P Johnson, S Jebb, T Williams, J Hippisley-Cox
– The BMJ
(2020)
371,
m3731
(doi: 10.1136/bmj.m3731)
Communicating personalised risks from COVID-19: guidelines from an empirical study
A Freeman, J Kerr, G Recchia, C Schneider, ACE Lawrence, L Finikarides, G Luoni, S Dryhurst, D Spiegelhalter
(2020)
2020.10.05.20206961
(doi: 10.1101/2020.10.05.20206961)
Use of “normal” risk to improve understanding of dangers of covid-19
D Spiegelhalter
– BMJ (Clinical research ed.)
(2020)
370,
m3259
(doi: 10.1136/bmj.m3259)
  • <
  • 2 of 43
  • >

Frontpage talks

There are no upcoming talks currently scheduled in this series.

Research Group

Statistical Laboratory

Email

D.Spiegelhalter@statslab.cam.ac.uk

Room

D2.06

Telephone

01223 337945

Personal homepage

https://www.dpmms.cam.ac.uk/~ds28/

    Study at Cambridge

    About the University

    Research at Cambridge